drugset / Trial / NCT04472494
Study of Abatacept in the Treatment of Hospitalized COVID-19 Participants With Respiratory Compromise
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the efficacy and safety of intravenous abatacept administered to hospitalized COVID-19 participants with respiratory compromise.
Timeline
- Start
- 2020-10-14
- Primary completion
- 2021-08-12
- Completion
- 2021-09-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Abatacept | Other / unclassified | — | Intravenous |